Form 4: Cassava CEO Buys 7,172 Shares in Open Market

Cassava Sciences President and CEO, Richard Barry, acquired 7,172 shares of common stock through a trust at an average price of $2.28 per share.

Summary

• Richard Barry, President & CEO and Director of Cassava Sciences Inc. (SAVA), purchased 7,172 shares of common stock.
• The transaction occurred on September 22, 2025, at a weighted average price of $2.28 per share.
• The shares were acquired in multiple open market transactions at prices ranging from $2.27 to $2.29 per share.
• Following this purchase, Barry beneficially owns 714,675 shares indirectly through a trust.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.

Sentiment

Score: 7

Explanation: The President and CEO's purchase of company stock, even if pre-planned, generally signals management confidence in the company's valuation and future prospects.

Positives

• Insider buying by a high-ranking executive (President & CEO, Director) can signal confidence in the company's future prospects.
• The purchase was made through a Rule 10b5-1 plan, indicating a pre-planned acquisition strategy rather than a reactive one.

Future Outlook

This Form 4 filing reports an insider transaction and does not contain forward-looking statements or guidance from the company.

Industry Context

This filing is specific to an individual's transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders may view the CEO's stock purchase as a positive signal of management's belief in the company's future performance, potentially boosting investor confidence.

Key Dates

Recommendation

The purchase of shares by the President and CEO indicates management's confidence in the company's value. While a positive signal, this single transaction alone is not sufficient to change a broader investment thesis without further financial and operational analysis. It reinforces a 'hold' position for existing investors and suggests potential for new investors to consider further due diligence.

Keywords

Cassava Sciences, SAVA, Insider Trading, Stock Purchase, CEO, Director, Form 4, Equity Acquisition, Richard Barry, 10b5-1 Plan